Concepedia

Thomas Plitz

TP

Statistics

Publications

11

Citations

1.3K

H-Index

11

Active since

1999

Affiliations

Ono Pharmaceutical (United States)(Current)

Technical University of Munich

Tallinn University of Technology

Merck Serono S.A. (Switzerland)

Thomas Plitz is an author at Ono Pharmaceutical (United States) specializing in medicine, clinical biochemistry, and wilson disease pharmacotherapy.

Publications per year

1999–2021

11

Publications

11

Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial

Ludwig Kappos, Hans‐Peter Hartung, Mark S. Freedman et al. · The Lancet Neurology · 2014 · 330 citations

Life Sciences, Neurology, Neuroimmunology +4

Mature Follicular Dendritic Cell Networks Depend on Expression of Lymphotoxin β Receptor by Radioresistant Stromal Cells and of Lymphotoxin β and Tumor Necrosis Factor by B Cells

Robert G. Endres, Marat Alimzhanov, Thomas Plitz et al. · The Journal of Experimental Medicine · 1999 · 314 citations · Full text

Life Sciences, Cell Biology, Immunology +13

Bis-choline tetrathiomolybdate in patients with Wilson's disease: an open-label, multicentre, phase 2 study

Karl Heinz Weiss, Frederick K. Askari, Anna Członkowska et al. · The Lancet. Gastroenterology & hepatology · 2017 · 169 citations

Medicine, Neurology, Pharmacotherapy +6

Copper(II)-binding equilibria in human blood

Tiina Kirsipuu, Anna Zadorožnaja, Julia Smirnova et al. · Scientific Reports · 2020 · 131 citations · Full text

Natural Sciences, Biochemistry, Chemistry +15

IL-18-Binding Protein Expression by Endothelial Cells and Macrophages Is Up-Regulated During Active Crohn’s Disease

Anne Corbaz, Tessa ten Hove, Suzanne Herren et al. · The Journal of Immunology · 2002 · 86 citations

Veterinary Medicine, Immunology, Pathology +17

1–5 of 11